Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Advances in Therapy|June 14, 2021
Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic FormulationDolores Ochoa, Manuel Román, Carmen Belmonte, et al.
Basic & Clinical Pharmacology & Toxicology|May 4, 2018
Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and AntidepressantsMiriam Saiz-Rodríguez, Carmen Belmonte, Manuel Román, et al.
European Journal of Dermatology : EJD|October 19, 2013
Association between psoriasis and polymorphisms in the TNF, IL12B, and IL23R genes in Spanish patientsTeresa Cabaleiro, Manuel Román, Elena Gallo, et al.
Molecular Therapy. Nucleic Acids|February 3, 2025
Clinical trial to compare safety and tolerability between intravenous infusion and bolus intravenous injection of ApTOLL in healthy volunteersMacarena Hernández-Jiménez, Samuel Martín-Vílchez, Gina Mejía-Abril, et al.
Pharmacogenomics|October 25, 2017
Pharmacogenetics of trazodone in healthy volunteers: association with pharmacokinetics, pharmacodynamics and safetyMiriam Saiz-Rodríguez, Carmen Belmonte, Nieves Derqui-Fernández, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 4, 2025
Apixaban kinetics could be influenced by sex, cytochrome P450 enzymes and SLC6A2 transporterEva González-Iglesias, Dolores Ochoa, Houwaida Abbes, et al.
Pharmaceutics|October 23, 2021
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine PharmacokineticsPablo Zubiaur, Paula Fernández-Campos, Marcos Navares-Gómez, et al.
Frontiers in Pharmacology|May 3, 2021
High-Fat Breakfast Increases Bioavailability of Albendazole Compared to Low-Fat Breakfast: Single-Dose Study in Healthy SubjectsDolores Ochoa, Miriam Saiz-Rodríguez, Esperanza González-Rojano, et al.
Journal of Personalized Medicine|April 3, 2021
SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin BioavailabilityPablo Zubiaur, Maria Dolores Benedicto, Gonzalo Villapalos-García, et al.
Pageof 12